Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Document › Details

Pharmicell Europe GmbH. (1/25/11). "Press Release: RNL Bio Takes Over the Majority Holding’s of Pharmicell Europe".

Region Region Berlin
  Country Germany
Organisations Organisation Pharmicell Europe GmbH
  Today RNL Europe GmbH
  Group RNL Bio (Group)
  Organisation 2 RNL Bio Co., Ltd.
  Group RNL Bio (Group)
Products Product cell therapy
  Product 2 cosmetics
Index term Index term FCB-Pharmicell–RNL Bio: investment, 201101 acquisition 99.5% of Pharmicell Europe GmbH to be renamed RNL Europe GmbH
Person Person Cho, Sung Hee (FCB-Pharmicell 201010– Managing Director of Pharmicell Europe GmbH)
     


Sunghee Cho, Managing Director of Pharmicell Europe GmbH announced that she had sold her 99.5% shareholding in Pharmicell Europe GmbH to RNL Bio Co. Ltd..

RNL Bio Co. Ltd is a Korea-based company engaged in the manufacturing of cell therapy products as well as stem cell cosmetics. All necessary notifications for the transaction are expected to be finished by the end of January.

With taking over of Pharmicell Europe, RNL Bio will expand the business areas of Pharmicell Europe into cosmetics and other stem cell related services while continuing the existing operations of fat derived stem cell products.

RNL Bio has announced to rename Pharmicell Europe into RNL Europe and make it headquarters for its pan-European operations.

Contact:
Sunghee Cho
+493033935994

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top